176 related articles for article (PubMed ID: 23574326)
21. Rapid ex vivo expansion of highly enriched human invariant natural killer T cells via single antigenic stimulation for cell therapy to prevent graft-versus-host disease.
Trujillo-Ocampo A; Cho HW; Herrmann AC; Ruiz-Vazquez W; Thornton AB; He H; Li D; Qazilbash MA; Ma Q; Porcelli SA; Shpall EJ; Molldrem J; Im JS
Cytotherapy; 2018 Aug; 20(8):1089-1101. PubMed ID: 30076070
[TBL] [Abstract][Full Text] [Related]
22. Migration and activation of T cells during development of graft-versus-host disease in a mouse model.
Wen HS; Wang JM; Zhou H; Gong SI; Gao L; Wu Y
Transplant Proc; 2013 Mar; 45(2):713-8. PubMed ID: 23498811
[TBL] [Abstract][Full Text] [Related]
23. Engraftment of canine peripheral blood lymphocytes into nonobese diabetic-severe combined immune deficient IL-2R common gamma chain null mice.
Foote JB; Kabir FM; Graff EC; Cattley RC; DeInnocentes P; Smith BF; Bird RC
Vet Immunol Immunopathol; 2014 Feb; 157(3-4):131-41. PubMed ID: 24368085
[TBL] [Abstract][Full Text] [Related]
24. Human CD4+ HLA-G+ regulatory T cells are potent suppressors of graft-versus-host disease in vivo.
Pankratz S; Bittner S; Herrmann AM; Schuhmann MK; Ruck T; Meuth SG; Wiendl H
FASEB J; 2014 Aug; 28(8):3435-45. PubMed ID: 24744146
[TBL] [Abstract][Full Text] [Related]
25. CD4-CD8-C.B-17 SCID thymocytes enter the CD4+CD8+ stage in the presence of neonatally grafted T cells.
Schneider MK; Grönvik KO
Scand J Immunol; 1998 May; 47(5):466-74. PubMed ID: 9627131
[TBL] [Abstract][Full Text] [Related]
26. Enhancement of suboptimal CD8 cytotoxic T cell effector function in vivo using antigen-specific CD80 defective T cells.
Puliaeva I; Soloviova K; Puliaiev M; Lang T; Puliaev R; Via CS
J Immunol; 2011 Jan; 186(1):291-304. PubMed ID: 21115734
[TBL] [Abstract][Full Text] [Related]
27. Alloimmune injury and rejection of human skin grafts on human peripheral blood lymphocyte-reconstituted non-obese diabetic severe combined immunodeficient beta2-microglobulin-null mice.
Turgeon NA; Banuelos SJ; Shultz LD; Lyons BL; Iwakoshi N; Greiner DL; Mordes JP; Rossini AA; Appel MC
Exp Biol Med (Maywood); 2003 Oct; 228(9):1096-104. PubMed ID: 14530522
[TBL] [Abstract][Full Text] [Related]
28. Migration of CD8+ T Cells into the Central Nervous System Gives Rise to Highly Potent Anti-HIV CD4dimCD8bright T Cells in a Wnt Signaling-Dependent Manner.
Richards MH; Narasipura SD; Seaton MS; Lutgen V; Al-Harthi L
J Immunol; 2016 Jan; 196(1):317-27. PubMed ID: 26582945
[TBL] [Abstract][Full Text] [Related]
29. [Interleukin-12 restores and promotes the T-cell immune function inhibited by 5-fluorouracil].
Chi PD; Li L; Fan YY; Wu CY
Ai Zheng; 2007 Aug; 26(8):801-8. PubMed ID: 17697537
[TBL] [Abstract][Full Text] [Related]
30. Non-obese diabetic-recombination activating gene-1 (NOD-Rag1 null) interleukin (IL)-2 receptor common gamma chain (IL2r gamma null) null mice: a radioresistant model for human lymphohaematopoietic engraftment.
Pearson T; Shultz LD; Miller D; King M; Laning J; Fodor W; Cuthbert A; Burzenski L; Gott B; Lyons B; Foreman O; Rossini AA; Greiner DL
Clin Exp Immunol; 2008 Nov; 154(2):270-84. PubMed ID: 18785974
[TBL] [Abstract][Full Text] [Related]
31. Pancreatic expression of B7 co-stimulatory molecules in the non-obese diabetic mouse.
Stephens LA; Kay TW
Int Immunol; 1995 Dec; 7(12):1885-95. PubMed ID: 8746558
[TBL] [Abstract][Full Text] [Related]
32. Long-term human CD34+ stem cell-engrafted nonobese diabetic/SCID/IL-2R gamma(null) mice show impaired CD8+ T cell maintenance and a functional arrest of immature NK cells.
André MC; Erbacher A; Gille C; Schmauke V; Goecke B; Hohberger A; Mang P; Wilhelm A; Mueller I; Herr W; Lang P; Handgretinger R; Hartwig UF
J Immunol; 2010 Sep; 185(5):2710-20. PubMed ID: 20668220
[TBL] [Abstract][Full Text] [Related]
33. Preconditioning therapy with lentiviral vector-programmed dendritic cells accelerates the homeostatic expansion of antigen-reactive human T cells in NOD.Rag1-/-.IL-2rγc-/- mice.
Salguero G; Sundarasetty BS; Borchers S; Wedekind D; Eiz-Vesper B; Velaga S; Jirmo AC; Behrens G; Warnecke G; Knöfel AK; Blasczyk R; Mischak-Weissinger E; Ganser A; Stripecke R
Hum Gene Ther; 2011 Oct; 22(10):1209-24. PubMed ID: 21574869
[TBL] [Abstract][Full Text] [Related]
34. Surrogate in vitro activation of innate immunity synergizes with interleukin-7 to unleash rapid antigen-driven outgrowth of CD4+ and CD8+ human peripheral blood T-cells naturally recognizing MUC1, HER2/neu and other tumor-associated antigens.
Pathangey LB; McCurry DB; Gendler SJ; Dominguez AL; Gorman JE; Pathangey G; Mihalik LA; Dang Y; Disis ML; Cohen PA
Oncotarget; 2017 Feb; 8(7):10785-10808. PubMed ID: 27974697
[TBL] [Abstract][Full Text] [Related]
35. Nanoparticles Engineered as Artificial Antigen-Presenting Cells Induce Human CD4
Giang S; Horwitz DA; Bickerton S; La Cava A
Front Immunol; 2021; 12():628059. PubMed ID: 34122401
[TBL] [Abstract][Full Text] [Related]
36. Highly sensitive model for xenogenic GVHD using severe immunodeficient NOG mice.
Ito R; Katano I; Kawai K; Hirata H; Ogura T; Kamisako T; Eto T; Ito M
Transplantation; 2009 Jun; 87(11):1654-8. PubMed ID: 19502956
[TBL] [Abstract][Full Text] [Related]
37. Distinct roles for donor- and host-derived antigen-presenting cells and costimulatory molecules in murine chronic graft-versus-host disease: requirements depend on target organ.
Anderson BE; McNiff JM; Jain D; Blazar BR; Shlomchik WD; Shlomchik MJ
Blood; 2005 Mar; 105(5):2227-34. PubMed ID: 15522961
[TBL] [Abstract][Full Text] [Related]
38. Dysregulated B7-1 and B7-2 expression on nonobese diabetic mouse B cells is associated with increased T cell costimulation and the development of insulitis.
Hussain S; Delovitch TL
J Immunol; 2005 Jan; 174(2):680-7. PubMed ID: 15634886
[TBL] [Abstract][Full Text] [Related]
39. Establishment of Humanized Mice from Peripheral Blood Mononuclear Cells or Cord Blood CD34+ Hematopoietic Stem Cells for Immune-Oncology Studies Evaluating New Therapeutic Agents.
Verma B; Wesa A
Curr Protoc Pharmacol; 2020 Jun; 89(1):e77. PubMed ID: 32453514
[TBL] [Abstract][Full Text] [Related]
40. Granzyme B-Mediated Activation-Induced Death of CD4+ T Cells Inhibits Murine Acute Graft-versus-Host Disease.
Du W; Leigh ND; Bian G; O'Neill RE; Mei L; Qiu J; Chen GL; Hahn T; Liu H; McCarthy PL; Cao X
J Immunol; 2015 Nov; 195(9):4514-23. PubMed ID: 26392464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]